Journal of Cellular and Molecular Medicine,
Journal Year:
2024,
Volume and Issue:
28(21)
Published: Nov. 1, 2024
Non-small
cell
lung
cancer
(NSCLC)
is
the
leading
cause
of
cancer-related
mortality,
with
tumour
heterogeneity,
fueled
by
stem
cells
(CSCs),
intricately
linked
to
treatment
resistance.
Therefore,
it
imperative
advance
therapeutic
strategies
targeting
CSCs
in
NSCLC.
In
this
study,
we
utilized
RNA
sequencing
investigate
metabolic
pathway
alterations
NSCLC
and
identified
a
crucial
role
nitric
oxide
(NO)
metabolism
governing
CSC
stemness,
primarily
through
modulation
Notch1
protein.
Mechanistically,
NO-induced
S-nitrosylation
facilitated
its
interaction
deubiquitylase
UCHL1,
increased
protein
stability
enhanced
stemness.
By
inhibiting
NO
synthesis
downregulating
UCHL1
expression,
validated
impact
on
Notch
signalling
Importantly,
effectively
reduced
populations
within
patient-derived
organoids
(PDOs)
during
radiotherapy.
This
mechanism
presents
promising
target
surmount
radiotherapy
resistance
treatment.
Antioxidants and Redox Signaling,
Journal Year:
2024,
Volume and Issue:
40(7-9), P. 369 - 432
Published: Feb. 1, 2024
Physiological
levels
of
reactive
oxygen
and
nitrogen
species
(ROS/RNS)
function
as
fundamental
messengers
for
many
cellular
developmental
processes
in
the
cardiovascular
system.
ROS/RNS
involved
cardiac
redox-signaling
originate
from
diverse
sources,
their
are
tightly
controlled
by
key
endogenous
antioxidant
systems
that
counteract
accumulation.
However,
dysregulated
redox-stress
resulting
inefficient
removal
leads
to
inflammation,
mitochondrial
dysfunction,
cell
death,
contributing
development
progression
disease
(CVD).
ACS Chemical Neuroscience,
Journal Year:
2024,
Volume and Issue:
15(9), P. 1828 - 1881
Published: April 22, 2024
Neurodegenerative
diseases
(NDs)
are
one
of
the
prominent
health
challenges
facing
contemporary
society,
and
many
efforts
have
been
made
to
overcome
(or)
control
it.
In
this
research
paper,
we
described
a
practical
one-pot
two-step
three-component
reaction
between
3,4-dihydronaphthalen-1(2H)-one
(1),
aryl(or
heteroaryl)glyoxal
monohydrates
(2a–h),
hydrazine
monohydrate
(NH2NH2•H2O)
for
regioselective
preparation
some
3-aryl(or
heteroaryl)-5,6-dihydrobenzo[h]cinnoline
derivatives
(3a–h).
After
synthesis
characterization
mentioned
cinnolines
(3a–h),
in
silico
multi-targeting
inhibitory
properties
these
heterocyclic
scaffolds
investigated
upon
various
Homo
sapiens-type
enzymes,
including
hMAO-A,
hMAO-B,
hAChE,
hBChE,
hBACE-1,
hBACE-2,
hNQO-1,
hNQO-2,
hnNOS,
hiNOS,
hPARP-1,
hPARP-2,
hLRRK-2(G2019S),
hGSK-3β,
hp38α
MAPK,
hJNK-3,
hOGA,
hNMDA
receptor,
hnSMase-2,
hIDO-1,
hCOMT,
hLIMK-1,
hLIMK-2,
hRIPK-1,
hUCH-L1,
hPARK-7,
hDHODH,
which
confirmed
their
functions
roles
neurodegenerative
(NDs),
based
on
molecular
docking
studies,
obtained
results
were
compared
with
wide
range
approved
drugs
well-known
(with
IC50,
EC50,
etc.)
compounds.
addition,
ADMET
prediction
analysis
was
performed
examine
prospective
drug
synthesized
compounds
The
from
studies
ADMET-related
data
demonstrated
that
series
heteroaryl)-5,6-dihydrobenzo[h]cinnolines
especially
hit
ones,
can
really
be
turned
into
potent
core
new
treatment
and/or
due
having
reactionable
locations,
they
able
further
organic
reactions
(such
as
cross-coupling
reactions),
expansion
(for
example,
using
other
types
monohydrates)
makes
avenue
designing
novel
efficient
purpose.
Antioxidants,
Journal Year:
2022,
Volume and Issue:
11(9), P. 1822 - 1822
Published: Sept. 16, 2022
Nicotinamide
adenine
dinucleotide
phosphate
(NADPH)
oxidases
regulate
production
of
reactive
oxygen
species
(ROS)
that
cause
oxidative
damage
to
cellular
components
but
also
redox
signaling
in
many
cell
types
with
essential
functions
the
cardiovascular
system.
Research
over
past
couple
decades
has
uncovered
mechanisms
by
which
NADPH
oxidase
(NOX)
enzymes
stress
and
compartmentalize
intracellular
endothelial
cells,
smooth
muscle
macrophages,
cardiomyocytes,
fibroblasts,
other
types.
NOX2
NOX4,
for
example,
distinct
cardiac
myocytes
pertinent
onset
progression
hypertrophy
heart
failure.
Heart
failure
preserved
ejection
fraction
(HFpEF),
accounts
at
least
half
all
cases
few
effective
treatments
date,
is
classically
associated
ventricular
diastolic
dysfunction,
i.e.,
defects
relaxation
and/or
filling.
However,
HFpEF
afflicts
multiple
organ
systems
systemic
pathologies
including
inflammation,
stress,
arterial
stiffening,
fibrosis,
renal,
adipose
tissue,
skeletal
dysfunction.
Basic
science
studies
clinical
data
suggest
a
role
myocardial
HFpEF,
evidence
from
animal
models
demonstrates
critical
NOX
function
several
HFpEF-associated
comorbidities.
Here,
we
discuss
roles
cells
are
development
dysfunction
outline
potential
implications.
Journal of Advanced Research,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Feb. 1, 2024
Despite
the
high
morbidity
and
mortality,
effective
therapies
for
heart
failure
with
preserved
fraction
(HFpEF)
are
limited
as
poor
understand
of
its
pathophysiological
basis.
This
study
was
aimed
to
characterize
cellular
heterogeneity
potential
mechanisms
HFpEF
at
single-cell
resolution.
An
mouse
model
induced
by
a
high-fat
diet
N-nitro-L-arginine
methyl
ester.
Cells
from
hearts
were
subjected
sequencing.
The
key
protein
expression
measured
Immunohistochemistry
immunofluorescence
staining.
In
hearts,
myocardial
fibroblasts
exhibited
higher
levels
fibrosis.
Furthermore,
an
increased
number
differentiated
into
high-metabolism
high-fibrosis
phenotypes.
genes
encoding
certain
pro-angiogenic
secreted
proteins
decreased
in
group,
confirmed
bulk
RNA
Additionally,
proportion
endothelial
cell
(EC)
lineages
group
significantly
downregulated,
low
angiogenesis
apoptosis
phenotypes
observed
these
EC
lineages.
Interestingly,
might
cross-link
via
over-secretion
ANGPTL4,
thus
displaying
anti-angiogenic
function.
staining
then
revealed
downregulation
vascular
density
upregulation
ANGPTL4
hearts.
Finally,
we
predicted
ANGPTL4as
druggable
target
using
DrugnomeAI.
conclusion,
this
comprehensively
characterized
impairment
resolution
proposed
that
secretion
may
be
mechanism
underlying
angiogenic
abnormality.
Journal of Clinical Medicine,
Journal Year:
2023,
Volume and Issue:
12(24), P. 7738 - 7738
Published: Dec. 17, 2023
Chronic
heart
failure
is
a
terminal
point
of
vast
majority
cardiac
or
extracardiac
causes
affecting
around
1-2%
the
global
population
and
more
than
10%
people
above
age
65.
Inflammation
persistently
associated
with
chronic
diseases,
contributing
in
many
cases
to
progression
disease.
Even
low
inflammatory
state,
past
studies
raised
question
whether
inflammation
constant
condition,
if
it
is,
rather,
triggered
different
amounts,
according
phenotype
failure.
By
evaluating
results
clinical
which
focused
on
proinflammatory
cytokines,
this
review
aims
identify
ones
that
are
independent
risk
factors
for
decompensation
cardiovascular
death.
This
assessed
current
evidence
concerning
activation
cascade,
but
also
future
possible
targets
response
modulation,
can
further
impact
course
Redox Biology,
Journal Year:
2024,
Volume and Issue:
72, P. 103166 - 103166
Published: April 26, 2024
S-nitrosylation
(SNO)
is
an
emerging
paradigm
of
redox
signaling
protecting
cells
against
oxidative
stress
in
the
heart.
Our
previous
studies
demonstrated
that
valosin-containing
protein
(VCP),
ATPase-associated
protein,
a
vital
mediator
heart
cardiac
and
ischemic
injury.
However,
molecular
regulations
conferred
by
VCP
are
not
fully
understood.
In
this
study,
we
explored
potential
role
SNO
using
multiple
cardiac-specific
genetically
modified
mouse
models
various
analytical
techniques
including
biotin
switch
assay,
liquid
chromatography,
mass
spectrometry,
western
blotting.
results
showed
overexpression
led
to
overall
increase
levels
SNO-modified
proteins
transgenic
(TG)
vs.
wild-type
(WT)
mice.
Mass
spectrometry
analysis
identified
mitochondrial
involved
respiration,
metabolism,
detoxification
as
primary
targets
modification
VCP-overexpressing
hearts.
Particularly,
found
itself
underwent
at
specific
cysteine
residue
its
N-domain.
Additionally,
our
study
glyceraldehyde
3-phosphate
dehydrogenase
(GAPDH),
key
enzyme
glycolysis,
also
experienced
increased
response
overexpression.
While
deletion
inducible
nitric
oxide
synthase
(iNOS)
TG
mice
did
affect
SNO,
it
abolish
complex
proteins,
suggesting
dual
mechanism
regulation
involving
both
iNOS-dependent
independent
pathways.
Overall,
findings
shed
light
on
post-translational
heart,
unveiling
previously
unrecognized
for
regulating
offering
new
insights
into
function
protection.
Biomedicine & Pharmacotherapy,
Journal Year:
2023,
Volume and Issue:
163, P. 114761 - 114761
Published: April 29, 2023
To
examine
the
protective
effect
of
vitamin
B12
against
myocardial
ischemia/reperfusion
(I/R)
injury
and
elucidate
its
underlying
mechanism
action.
Mice
were
subjected
to
I/R
by
left
anterior
descending
coronary
artery
(LAD)
occlusion
followed
24
h
reperfusion.
Cardiac
function
evaluated
echocardiography,
triphenyl
tetrazolium
chloride
(TTC)
cardiac
troponin
T
(cTnT)
staining,
measuring
lactate
dehydrogenase
(LDH)
levels.
In
addition,
various
molecular
biochemical
methods,
as
well
RNA
sequencing
used
determine
effects
action
on
injury.
We
found
that
high
doses
inhibited
Furthermore,
our
data
indicated
supplementation
alleviated
dysfunction
mitigating
oxidative
stress
apoptosis
through
downregulation
Nox2,
Ac-SOD2/SOD2
Bax/Bcl-2
ratios
cleaved
caspase-3
expression,
upregulation
SIRT3
expression
AMPK
activity.
However,
these
largely
reversed
following
treatment
with
inhibitor,
3-TYP.
Our
RNA-sequencing
further
demonstrated
reduced
inflammation
during
High
supplements
improved
suppressing
accumulation
reactive
oxygen
species
tissue
modulation
SIRT3/AMPK
signaling
pathway,
while
reducing
inflammation.
findings
suggested
administered
at
could
be
a
potential
therapy
for
damage.